Archives
MK-8745: A Context-Aware Aurora A Workflow
2026-09-16
MK-8745 is a potent and selective Aurora A inhibitor for dissecting mitotic control, apoptosis, and tumor vulnerability. This article translates retinoblastoma findings into practical assay decisions across cell-based and xenograft research while clarifying model selection, endpoint timing, and interpretation limits.
Chicken Gasdermins Reveal Caspase-Driven Pyroptosis
2026-09-16
The reference study defines a previously undercharacterized avian pyroptosis pathway by showing that chicken gasdermin A and gasdermin E are cleaved by distinct caspases and that their amino-terminal fragments can damage membranes and restrict bacterial growth. Its combination of biochemical cleavage mapping, cell-based pore-function assays, and infection models provides a framework for studying species-specific gasdermin biology while highlighting the limits of directly transferring mammalian inflammasome models to birds.
Auranofin and Metabolic Stress in HCC Research
2026-09-15
Auranofin is a thioredoxin reductase inhibitor that can help researchers interrogate the relationship between redox control and metabolic plasticity in hepatocellular carcinoma. This article translates recent FOXO3/YAP findings into a rigorous, redox-aware assay strategy without overstating unvalidated mechanisms.
CHIR-99021 for Stem Cell and Organoid Workflows
2026-09-15
CHIR-99021 (CT99021) provides reversible, selective GSK-3α/β control for tuning pluripotency, endodermal patterning, and organoid maturation. This guide translates atlas-based developmental benchmarking into practical dosing, assay design, and troubleshooting strategies.
CCG-1423: A Pathway-Resolved Assay Strategy
2026-09-14
CCG-1423 is a RhoA inhibitor that helps separate MRTF-A transcriptional signaling from ROCK-dependent cytoskeletal remodeling. This article translates recent RhoA/ROCK pathway findings into a practical, evidence-aware framework for cancer research, apoptosis assay design, and cross-domain interpretation.
BAX–BAK Mosaic Rings in Apoptotic Mitochondria
2026-09-14
The reference study uses live- and fixed-cell STED microscopy to show that endogenous BAX and BAK assemble into heterogeneous mosaic rings on apoptotic mitochondria, rather than a uniform oligomeric structure. Its findings place BAK recruitment slightly ahead of BAX and show why endogenous protein measurements are essential for interpreting mitochondrial outer membrane permeabilization.
Aging Lens Epithelium and Ferroptosis Susceptibility
2026-09-13
Wei and colleagues show that aging lens epithelial cells become unusually vulnerable to ferroptosis, linking age-related redox imbalance, lipid peroxidation, iron accumulation, and impaired glutathione protection. Their combination of human and mouse models, glutathione perturbation, RSL3 and erastin exposure, and transcriptome analysis provides a mechanistic framework for studying ferroptosis in cataractogenesis.
WEHI-539: A BCL-XL Inhibitor Workflow
2026-09-12
WEHI-539 is a selective BCL-XL inhibitor for separating BCL-XL dependence from broader apoptotic stress. This practical guide connects dose-response testing, mitochondrial apoptosis assays, cancer stem cell sensitization, and MCL-1-focused combination studies.
1-methyl Adenosine Assay Workflows
2026-09-11
Build reliable 1-methyl Adenosine workflows for cell perturbation, intracellular nucleoside profiling, and biomarker discovery. The practical strategy combines controlled dosing with stable isotope-diluted UHPLC–MS/MS, chromatographic isomer separation, and matrix cleanup.
MK-571 Workflows for Inflammation Research
2026-09-11
MK-571 (L-660,711) helps separate cysteinyl leukotriene signaling from ABCC1/MRP1-linked drug transport in airway and macrophage assays. This practical guide covers assay setup, dosing logic, cross-model controls, and troubleshooting for bronchoconstriction, allergic inflammation, and chemotherapy-stress workflows.
RSL3 Workflows for GPX4-Driven Ferroptosis
2026-09-10
RSL3 provides a fast, mechanistically focused way to test GPX4-dependent ferroptosis, from HCC pathway studies to RAS-driven cancer models. This guide combines practical handling, quantitative assay conditions, TEAD2-informed experimental design, and troubleshooting for more reproducible oxidative cell-death results.
Schizophrenia Risk Pathways in Developing Neurons
2026-09-10
Liu et al. used cell-type-resolved human iPSC models to show that schizophrenia-associated loci converge on different developmental pathways in cortical interneurons and glutamatergic neurons. The study links interneuron risk loci to PKC hyperactivity and arborization defects, while glutamatergic-neuron loci affect ion transport and calcium currents, providing a framework for cell-specific mechanistic studies.
Amiloride (MK-870) for Ion Transport Workflows
2026-09-09
Amiloride (MK-870) enables controlled perturbation of epithelial sodium transport, with practical value in sodium channel research, cystic fibrosis research, and hypertension research. Its negative result in a reovirus-entry study also makes it a useful specificity control when testing cellular endocytosis modulation rather than a presumed universal uptake inhibitor.
SM-164: Reliable Apoptosis Assay Workflows
2026-09-09
This scenario-based guide explains how SM-164 (SKU A8815), a bivalent Smac mimetic, can support interpretable viability, proliferation, and apoptosis experiments. It covers mechanism, solvent compatibility, handling, orthogonal readouts, and practical criteria for selecting a reliable research reagent.
Sinapine Targets PLCβ3 EF Hands in Cardiovascular Disease
2026-09-08
The reference study identifies the PLCβ3 EF-hand domain, particularly Asn-260, as a druggable site for disrupting the Gαq–PLCβ3 interaction in RAAS-driven cardiovascular disease. By combining chemical-probe target identification, biochemical validation, and aldosteronism and hypertension models, the authors position sinapine as a more pathway-focused alternative to broad Gαq or PLC inhibition.
609 records 8/41 page Previous Next First page 上5页 678910 下5页 Last page